ARMC2-AS1

Across TCGA pan-cancer cohorts, ARMC2-AS1 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated ARMC2-AS1 data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher ARMC2-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ARMC2-AS1 expression acts as an unfavorable survival marker, although some lineages such as PAAD and CHOL show a favorable association.

LGG, PAAD, and CHOL are the cancer types where ARMC2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	OS	Median	All	0.739	0.878	<.001	50	view →
PAAD	DFS	Median	All	0.363	0.207	.005	34	view →
CHOL	DFS	Tertile	All	0.762	0.295	.009	30	view →
LUAD	DFS	Median	IV	0.326	0.766	.017	26	view →
HNSC	OS	Tertile	II,III,IV	0.843	0.717	.013	21	view →
BLCA	DFS	Tertile	All	0.275	0.556	<.001	18	view →
BRCA	OS	Median	III,IV	0.936	0.869	.005	11	view →
UVM	DFS	Tertile	III,IV	0.318	0.597	.031	9	view →
MESO	DFS	Median	IV	0.203	0.452	.021	9	view →
TGCT	OS	Quartile	All	0.907	1.000	.011	8	view →
READ	OS	Median	All	1.000	0.870	.009	7	view →
KIRC	DFS	Median	All	0.590	0.703	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

ARMC2-AS1–LGG (OS)

Open the LGG breakdown →